Evropska unija - latvijščina - EMA (European Medicines Agency)

leo laboratories ltd. - ingenol mebutate - keratozes, aktinika - dermatoloģijā lietojamie antiobiotiskie un ķīmiskās par dermatoloģijas izmantot, citas ķīmiskās - picato ir norādīts kā ādas ārstēšanas nav hyperkeratotic, kas nav hipertrofiska aktīniskā keratoze pieaugušajiem.

Evropska unija - latvijščina - EMA (European Medicines Agency)

leo pharma a/s - tacrolimus - dermatīts, atopisks - citi dermatoloģiski preparāti - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. sastopamas četras vai vairāk reizes gadā), kas ir bijusi pirmā atbilde, lai maksimāli sešas nedēļas ārstēšanai divreiz dienā takrolīma ziede (bojājumi noskaidroti, gandrīz noskaidroti vai daļēji ietekmē).

Latvija - latvijščina - Pārtikas un veterinārais dienests, Zemkopības ministrija

zoetis belgium s.a., beļģija - live attenuated canine distemper virus, strain snyder hill, live attenuated canine adenovirus type 2 (cav2), strain manhattan, live attenuated canine parainfluenza virus, strain nl-cpi-5, live attenuated canine parvovirus, strain nl-35-d, inactivated leptospira canicola, strain c-51, inactivated leptospira icterohaemorrhagiae, strain nadl (11403) - liofilizāts un šķīdinātājs šķīduma injekcijām pagatavošanai - suņi

Latvija - latvijščina - Pārtikas un veterinārais dienests, Zemkopības ministrija

vetoquinol biowet sp. z o.o., polija - ketamīna hidrohlorīds - šķīdums injekcijām - 100 mg/ml - kaķi; suņi

Latvija - latvijščina - Pārtikas un veterinārais dienests, Zemkopības ministrija

ceva sante animale,, francija - pimobendan - košļājamās tabletes - 1,25 mg - suņi

Latvija - latvijščina - Pārtikas un veterinārais dienests, Zemkopības ministrija

ceva sante animale,, francija - pimobendan - košļājamās tabletes - 5 mg - suņi

Evropska unija - latvijščina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - chondrogenic izraisīto zirgu alogēnas perifēro asins mezenhimālas cilmes šūnas - other drugs for disorders of the musculo-skeletal system - zirgi - samazinājums vieglas līdz vidēji periodisko klibumu, kas saistīti ar ne-septisko locītavu iekaisumu zirgi.

Evropska unija - latvijščina - EMA (European Medicines Agency)

plethora pharma solutions limited - lidokaīns, prilocaine - priekšlaicīga ejakulācija - anestēzijas līdzekļi - senstend ir indicēts, lai ārstētu primārajā priekšlaicīgu ejakulāciju pieauguši vīrieši.

Evropska unija - latvijščina - EMA (European Medicines Agency)

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Evropska unija - latvijščina - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiski līdzekļi - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.